| Article Access Statistics|
| Viewed||3089 |
| Printed||109 |
| Emailed||0 |
| PDF Downloaded||183 |
| Comments ||[Add] |
| Cited by others ||1 |
Click on image for details.
|Year : 2007 | Volume
| Issue : 2 | Page : 149
Usefulness of prenatal detection of RhD typing by molecular analysis in Indians
SS Kulkarni, AC Gorakshakar, RB Colah, SC Gupte, D Mohanty
Red Cell Serology and Hematogenetics, Institute of Immunohaematology, 13th Floor, New Multistoreyed Building, KEM Hospital Campus, Parel, Mumbai - 400 012, India
R B Colah
Red Cell Serology and Hematogenetics, Institute of Immunohaematology, 13th Floor, New Multistoreyed Building, KEM Hospital Campus, Parel, Mumbai - 400 012
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Kulkarni S S, Gorakshakar A C, Colah R B, Gupte S C, Mohanty D. Usefulness of prenatal detection of RhD typing by molecular analysis in Indians. J Postgrad Med 2007;53:149
|How to cite this URL:|
Kulkarni S S, Gorakshakar A C, Colah R B, Gupte S C, Mohanty D. Usefulness of prenatal detection of RhD typing by molecular analysis in Indians. J Postgrad Med [serial online] 2007 [cited 2020 Nov 24];53:149. Available from: https://www.jpgmonline.com/text.asp?2007/53/2/149/32225
The Rh blood group system is one of the most polymorphic systems known in humans. The Rh locus is on the short arm of chromosome 1p34 - p36 and consists of two closely linked, highly homologous structural genes RHD and RHCE encoding D and CcEe antigens respectively. The prenatal determination of fetal blood group status early in pregnancy imparts considerable benefit to both the mother and the fetus. Prenatal diagnosis of fetal RhD status by polymerase chain reaction (PCR) exploits the structural differences between the RHD and RHCE gene., Here, we have evaluated the usefulness of fetal RhD typing by PCR using chorionic villus (CV) tissue DNA.
Transabdominal CV sampling was done in 15 cases between nine to twelve and a half weeks gestation for prenatal diagnosis of thalassemia after informed consent. The DNA of these family members along with their CV DNA was used for RhD typing by PCR. The following primers viz. A1 (5'TGTGTTGTAACCGAGT3'), A2 (5'ACATDCCATTG CCG3'), A3 (5'TAAGCAAAGCATCCAA3'), A4 (5'ATGGT GAGATTCTCCT3') were used for PCR according to the method of Bennett et al 1993. RhD negative cases show a 136bp fragment, whereas RhD positive cases show two fragments (136 bp and 186 bp).
Analysis of the RhD genotype in chorionic villus tissue DNA samples from 15 fetuses and their families was performed. There was complete agreement on the results of RhD DNA typing of chorionic villus sample with the cord blood tested after delivery by serological methods [Figure - 1].
Despite the widespread use of prophylactic anti-D, Rh-alloimmunization continues to occur in pregnancy. Severe alloimmunization could warrant exchange transfusion to prevent bilirubin encephalopathy in newborns. The incidence of Rh-alloimmunization has declined significantly from 5% to 1.7% after the initiating the practice of administration of anti-D immunoglobulin to all-RhD negative women registered in the antenatal clinic. The incidence can be further reduced by use of prophylactic anti-D antenatally. Molecular typing of RhD is not yet routinely done in India. We have demonstrated that the fetal RhD genotype can be reliably and rapidly determined from CV tissue DNA by PCR. This could facilitate decision-making, when the mother is RhD alloimmunized and the father is heterozygous for the D allele. A negative result enables early reassurance for the couple that the baby will be unaffected and that serial intrauterine transfusions will not be required. The knowledge that the fetus is RhD positive allows for undertaking a more cautious approach.,, Molecular RhD typing can be performed with CV sample or amniotic fluid sample. The results can be obtained within 24h of sample collection in laboratories having DNA-based testing facilities. RhD PCR can also be useful to indicate requirement of antenatal anti-D prophylaxis in RhD negative women.
| :: References|| |
|1.||Avent ND. Antenatal genotyping of the blood group of the fetus. Vox Sang 1998;74:365-74. [PUBMED] |
|2.||Flegel WA, Wagner FF, Muller TH, Gassener C. Rh phenotypes prediction by DNA typing and its application to practice. Transfus Med 1998;8:281-302. |
|3.||Bennett PR, Le Van Kim C, Colin Y, Warwick RM, Cherif-Zahar B, Fisk NM, et al . Prenatal determination of fetal Rh D type by DNA amplification. N Eng J Med 1993;329:607-10. |
|4.||Gupte SC, Kulkarni SS. Incidence of Rh immunization between 1981 and 1992. Nat Med J India 1994;7:65-6. |
|5.||Parnet-Mathieu F, Gillet G, Pullandre P, Colin Y, Levan Kim C, Cartron JP, et al . RHD genotyping of amniocytes and Rh prophylaxis. A 3 years experience of 329 cases. Vox Sang 2000;79:27. |
[Figure - 1]
|This article has been cited by|
||Current awareness in prenatal diagnosis
| || |
| ||Prenatal Diagnosis. 2007; 27(11): 1085 |
|[Pubmed] | [DOI]|